Genomics

Dataset Information

0

NuRD subunit CHD4 regulates super-enhancer accessibility in Rhabdomyosarcoma and represents a general tumor dependency


ABSTRACT: ATP-dependent chromatin remodelers modulate gene expression by regulating genome accessibility and can contribute to tumorigenesis. In fusion-positive rhabdomyosarcoma (FP-RMS), we have previously identified the chromatin remodeler and NuRD subunit CHD4 as an essential gene for tumor survival. Here, we demonstrate that the FP-RMS vulnerability to CHD4 goes beyond its function as a NuRD member. Mechanistically, CHD4 interacts with BRD4 and co-localizes with the tumor driver and fusion protein PAX3-FOXO1 at super-enhancers where it generates a chromatin architecture permissive for the binding of the fusion protein. This allows the positioning of RNA polymerase 2 at promoters and the expression of the oncogenic program of PAX3-FOXO1. Additionally, analysis of genome-wide cancer dependency databases identifies CHD4 amongst the NuRD subunits as general novel cancer vulnerability. Our findings describe, for the first time, CHD4 as a regulator of super-enhancer-mediated gene expression and establish this chromatin remodeler as an unexpected broad tumor susceptibility.

ORGANISM(S): Homo sapiens

PROVIDER: GSE155861 | GEO | 2020/08/08

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2019-12-20 | GSE140115 | GEO
2020-08-11 | PXD015231 | Pride
2024-10-25 | GSE279336 | GEO
2024-10-25 | GSE279335 | GEO
2023-12-31 | GSE219199 | GEO
2021-04-01 | GSE162052 | GEO
2020-11-20 | MSV000086494 | MassIVE
2022-09-06 | GSE198755 | GEO
2022-09-06 | GSE198754 | GEO
2022-09-06 | GSE198753 | GEO